DIPG-35. BIOLOGICAL MEDICINE FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) ERADICATION: RESULTS OF THE THREE ARM BIOMARKER-DRIVEN RANDOMIZED BIOMEDE 1.0 TRIAL

Despite 50 years of clinical trials, no improvement of survival has been observed in DIPG and most children die within 2 years of diagnosis. Only radiotherapy transiently controls disease progression. The study was conceived as a randomized multi-arm multi-stage program. It started with an open-labe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Grill, Jacques, Teuff, Gwenael Le, Nysom, Karsten, Blomgren, Klas, Hargrave, Darren, MacCowage, Geoff, Bautista, Francisco, Van Vuurden, Dannis, Dangouloff-Ros, Volodia, Puget, Stephanie, Varlet, Pascale, Debily, Marie-Anne, Vassal, Gilles, Deley, Marie-Cecile Le
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Diffuse Midline Glioma/DIPG
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715776/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.083
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares